Followers | 664 |
Posts | 46911 |
Boards Moderated | 2 |
Alias Born | 03/30/2009 |
Sunday, April 19, 2015 7:48:23 PM
BTW, I came across this article in the WSJ re: Keytruda and melanoma:
Merck’s Keytruda Shows Improved Survival Odds in Melanoma
Immunotherapy displayed better survival rates compared with Bristol-Myers’s Yervoy
http://www.wsj.com/articles/mercks-keytruda-shows-improved-survival-odds-for-melanoma-patients-1429448169
The article is dated today but, wasn't there a trial, involving Keytruda, that was stopped early because Merck's drug showed promising results over a rival's drug? Isn't this article discussing the same?
"You should grow like an onion with your head in the ground."--Yiddish epithet
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM